Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BVF INC/IL | 6.29M | $24.0M | 7.78% | -- | 2026-06-30 |
| BlackRock, Inc. | 5.12M | $20.0M | 6.33% | +741.6K | 2026-06-30 |
| Defilade Capital Management, L.P. | 3.53M | $13.0M | 4.36% | -38.8K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.42M | $13.0M | 4.22% | +124.1K | 2026-06-30 |
| GOLDMAN SACHS GROUP INC | 2.51M | $9.0M | 3.10% | +2.14M | 2026-06-30 |
| Ensign Peak Advisors, Inc | 2.10M | $8.0M | 2.60% | -363.7K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.96M | $7.0M | 2.42% | +164.8K | 2026-06-30 |
| Catalio Capital Management, LP | 1.70M | $6.0M | 2.10% | +55.3K | 2026-06-30 |
| STATE STREET CORP | 1.62M | $6.0M | 2.01% | +467.3K | 2026-06-30 |
| Zimmer Partners, LP | 1.60M | $6.0M | 1.97% | -278.4K | 2026-06-30 |
